课题基金 / 基金详情

Investigating Molecular and Cellular Heterogeneity within the Human Kidney using Multimodal Imaging Approaches

Investigating Molecular and Cellular Heterogeneity within the Human Kidney using Multimodal Imaging Approaches
使用多模态成像方法研究人肾脏内的分子和细胞异质性
批准号:
10386620
负责人:
Elizabeth Kathleen Neumann
金额:
$2.45万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-02-01 至 2022-05-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY. The chemical interplay within cellular networks facilitates diverse functions of organ systems and contributes to human health and disease. The human kidney is a complex organ composed of an average of one million nephrons that individually contain at least 26 distinct cell types. Nephrons then form a network consisting of a glomerulus that is linked to various tubular segments, capillaries, lymphatics, and peritubular interstitial spaces. This dynamic cellular network not only varies from one individual to another but throughout the kidney itself. Because the kidney is responsible for waste management, electrolyte balance, blood pressure control, and red blood cell production, differences in cellular composition or chemistry can greatly impact efficiency or disease progression. To date, there is not complete understanding of the natural variance in the numbers of specific cell types nor their respective chemistries within the kidney. Even less is known about how these metrics relate to sex and race. Here, we propose to use a combination of imaging mass spectrometry (IMS) and co-detection by indexing multiplexed immunofluorescence (CODEX IF) to establish a baseline of what molecules and cellular populations constitute a normal, healthy kidney as well as how these change as a function of specific patient demographics. While understanding the cellular and molecular constituents of healthy kidney tissue is important by itself, this knowledge has clear implications in the definition of different disease states and phenotypes, such as diabetic nephropathy and organ failure. We predict accomplishing these tasks through two key aims: 1. determine the molecular profiles of functional tissue regions (e.g. glomeruli, cortex, and medulla) within the human kidney as the function of sex and race using imaging mass spectrometry and 2. investigate the composition of cell types within the medulla, cortex, and renal pelvis as a function of these demographics using CODEX IF. In brief, IMS allows visualization of hundreds to thousands of endogenous metabolites and lipids, while CODEX IF labels cell types and structures at a higher plexity than traditional IF methods. Though both approaches provide essential information on their own, we can synergistically combine the data to obtain molecular profiles of individual cell types to better parse the chemical differences between regions of tissue and human patients. Ultimately, there will be molecules that are detected within every tissue as well as cell compositions that are conserved among all the assayed patients. Additionally, there will likely be rare molecules or unique cellular profiles that differ from the average. Both events are essential for understanding heathy function with a longer-term goal of determining how these similarities and differences contribute to disease development and progression. While a large-scale project, I am aided by many scientific leaders (see letters of support) who are invested in my success and the ultimate success of the project. Our team will build a comprehensive chemical and cellular atlas of the human kidney with emphasis on sex and race.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: